KATIE BARRITT: Open Payments
NPI 1336543289 · HAMPSTEAD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 22 payments from 9 companies in 2025. Trend: 2023 $150 · 2024 $469 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $180 |
| Amgen Inc. | 3 | $48 |
| Exact Sciences Corporation | 2 | $44 |
| Novo Nordisk Inc | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: QULIPTA, VRAYLAR, OTEZLA, Cologuard Collection Kit, Auvelity, Wegovy, Dyanavel XR, Ozempic.
Industry payments across MD — which companies pay providers there.
